Transfusion immunomodulation - the case for leukoreduced and (perhaps) washed transfusions

Blood Cells, Molecules, and Diseases

Volumn 50, Issue 1, 2013, Pages 61-68

  Lannan, Katie L ^a   Sahler, Julie ^a   Spinelli, Sherry L ^a   Phipps, Richard P ^a   Blumberg, Neil ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Leukoreduction; Platelet; Red blood cell; Transfusion; Washing

Indexed keywords

ALLOIMMUNIZATION; ARTICLE; BLOOD GROUP; BLOOD TRANSFUSION; CRITICALLY ILL PATIENT; DOWN REGULATION; HEMOSTASIS; HISTOCOMPATIBILITY; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; MORTALITY; NATURAL KILLER CELL; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE; THROMBOCYTE TRANSFUSION;

BLOOD BANKS; BLOOD TRANSFUSION; CRITICAL ILLNESS; CRYOPRESERVATION; CYTAPHERESIS; HUMANS; IMMUNE SYSTEM; IMMUNOMODULATION; LEUKOCYTE REDUCTION PROCEDURES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS;

ANIMALIA;

EID: 84869886456     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.08.009     Document Type: Article

References (81)

1. Wang D., Sun J., Solomon S.B., Klein H.G., Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012, 52:1184-1195.
2. Steiner M.E., Assmann S.F., Levy J.H., et al. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus. Apher. Sci. 2010, 43:107-116.
3. Lacroix J., Hébert P., Fergusson D., et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus. Med. Rev. 2011, 25:197-205.
4. van de Watering L.M., Hermans J., Houbiers J.G., et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998, 97:562-568.
5. Bilgin Y.M., van de Watering L.M., Eijsman L., et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004, 109:2755-2760.
6. Blumberg N., Zhao H., Wang H., et al. The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion 2007, 47:573-581.
7. Cholette J.M., Henrichs K.F., Alfieris G.M., et al. Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: results of a prospective, randomized, controlled clinical trial. Pediatr. Crit. Care Med. 2012, 13:290-299.
8. Sparrow R.L., Patton K.A. Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 2004, 44:722-730.
9. Benson D.D., Beck A.W., Burdine M.S., et al. Accumulation of pro-cancer cytokines in the plasma fraction of stored packed red cells. J. Gastrointest. Surg. 2012, 16:460-468.
10. Davenport R.D., Kunkel S.L. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfus. Med. Rev. 1994, 8:157-168.
11. Kaufman J., Spinelli S.L., Schultz E., Blumberg N., Phipps R.P. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J. Thromb. Haemost. 2007, 5:788-796.
12. Phipps R.P., Kaufman J., Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001, 357:2023-2024.
13. Yin K., Halushka P.V., Yan Y.T., Wong P.Y. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J. Pharmacol. Exp. Ther. 1994, 270:1192-1196.
14. Silliman C.C., Moore E.E., Kelher M.R., et al. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011, 51:2549-2554.
15. Villagra J., Shiva S., Hunter L.A., et al. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007, 110:2166-2172.
16. Winterbourn C.C. Free-radical production and oxidative reactions of hemoglobin. Environ. Health Perspect. 1985, 64:321-330.
17. Xiong Z., Cavaretta J., Qu L., et al. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 2011, 51:610-621.
18. Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb. Haemost. 2009, 101:439-451.
19. Thomas S., Beard M., Garwood M., Callaert M., Cardigan R. Platelet concentrates produced from whole blood using the Atreus processing system. Vox Sang. 2009, 97:93-101.
20. Lawrie A.S., Albanyan A., Cardigan R.A., Mackie I.J., Harrison P. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang. 2009, 96:206-212.
21. Moroff G., Holme S., Keegan T., Heaton A. Storage of ADSOL-preserved red cells at 2.5 and 5.5 degrees C: comparable retention of in vitro properties. Vox Sang. 1990, 59:136-139.
22. Bonaventura J. Clinical implications of the loss of vasoactive nitric oxide during red blood cell storage. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19165-19166.
23. Bosman G.J., Werre J.M., Willekens F.L., Novotný V.M. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus. Med. 2008, 18:335-347.
24. Wadhwa M., Seghatchian M.J., Dilger P., et al. Cytokines in WBC-reduced apheresis PCs during storage: a comparison of two WBC-reduction methods. Transfusion 2000, 40:1118-1126.
25. Wadhwa M., Krailadsiri P., Dilger P., et al. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates. Vox Sang. 2002, 83:125-136.
26. Phelan H.A., Gonzalez R.P., Patel H.D., et al. Prestorage leukoreduction ameliorates the effects of aging on banked blood. J. Trauma 2010, 69:330-337.
27. Phelan H.A., Eastman A.L., Aldy K., et al. Prestorage leukoreduction abrogates the detrimental effect of aging on packed red cells transfused after trauma: a prospective cohort study. Am. J. Surg. 2012, 203:198-204.
28. Hébert P.C., Fergusson D., Blajchman M.A., et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003, 289:1941-1949.
29. King K.E., Shirey R.S., Thoman S.K., et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004, 44:25-29.
30. Blumberg N., Heal J.M., Gettings K.F., et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010, 50:2738-2744.
31. Dzik W.H., Anderson J.K., O'Neill E.M., et al. A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002, 42:1114-1122.
32. Geiger T.L., Howard S.C. Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?. Transfus. Med. Rev. 2007, 21:1-12.
33. Hendrickson J.E., Hillyer C.D. Noninfectious serious hazards of transfusion. Anesth. Analg. 2009, 108:759-769.
34. Romano G., Mastroianni C., Bancone C., et al. Leukoreduction program for red blood cell transfusions in coronary surgery: association with reduced acute kidney injury and in-hospital mortality. J. Thorac. Cardiovasc. Surg. 2010, 140:188-195.
35. Plurad D., Belzberg H., Schulman I., et al. Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury. Am. Surg. 2008, 74:117-123.
36. Netzer G., Shah C.V., Iwashyna T.J., et al. Association of RBC transfusion with mortality in patients with acute lung injury. Chest 2007, 132:1116-1123.
37. Miyaji K., Miyamoto T., Kohira S., et al. The effectiveness of prestorage leukocyte-reduced red blood cell transfusion on perioperative inflammatory response with a miniaturized biocompatible bypass system. J. Thorac. Cardiovasc. Surg. 2010, 139:1561-1567.
38. Fung M.K., Rao N., Rice J., et al. Leukoreduction in the setting of open heart surgery: a prospective cohort-controlled study. Transfusion 2004, 44:30-35.
39. Fung M.K., Moore K., Ridenour M., Mook W., Triulzi D.J. Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery. Transfusion 2006, 46:386-391.
40. Blumberg N., Heal J.M., Cowles J.W., et al. Leukocyte-reduced transfusions in cardiac surgery results of an implementation trial. Am. J. Clin. Pathol. 2002, 118:376-381.
41. van Hilten J.A., van de Watering L.M., van Bockel J.H., et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ 2004, 328:1281.
42. Friese R.S., Sperry J.L., Phelan H.A., Gentilello L.M. The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients. Am. J. Surg. 2008, 196:56-61.
43. Phelan H.A., Sperry J.L., Friese R.S. Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients. J. Surg. Res. 2007, 138:32-36.
44. Nathens A.B., Nester T.A., Rubenfeld G.D., Nirula R., Gernsheimer T.B. The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock 2006, 26:342-347.
45. Vamvakas E.C. Why have meta-analyses of randomized controlled trials of the association between non-white-blood-cell-reduced allogeneic blood transfusion and postoperative infection produced discordant results?. Vox Sang. 2007, 93:196-207.
46. Jensen L.S., Andersen A.J., Christiansen P.M., et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br. J. Surg. 1992, 79:513-516.
47. Jensen L.S., Kissmeyer-Nielsen P., Wolff B., Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996, 348:841-845.
48. Houbiers J.G., Brand A., van de Watering L.M., et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994, 344:573-578.
49. Tartter P.I., Mohandas K., Azar P., et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am. J. Surg. 1998, 176:462-466.
50. Titlestad I.L., Ebbesen L.S., Ainsworth A.P., et al. Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study. Int. J. Colorectal Dis. 2001, 16:147-153.
51. Vamvakas E.C., Blajchman M.A. Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion. Transfus. Med. Rev. 2000, 14:23-33.
52. Vamvakas E.C. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus. Med. Rev. 2002, 16:304-314.
53. Vandromme M.J., McGwin G., Weinberg J.A. Blood transfusion in the critically ill: does storage age matter?. Scand. J. Trauma Resusc. Emerg. Med. 2009, 17:35.
54. Zallen G., Offner P.J., Moore E.E., et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am. J. Surg. 1999, 178:570-572.
55. Offner P.J., Moore E.E., Biffl W.L., Johnson J.L., Silliman C.C. Increased rate of infection associated with transfusion of old blood after severe injury. Arch. Surg. 2002, 137:711-716. (discussion 716-7).
56. Stone P.W., Larson E., Kawar L.N. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am. J. Infect. Control. 2002, 30:145-152.
57. Blumberg N., Heal J.M. Blood transfusion immunomodulation: the silent epidemic. Arch. Pathol. Lab. Med. 1998, 122:117-119.
58. Blumberg N., Heal J.M. Mortality risks, costs, and decision making in transfusion medicine. Am. J. Clin. Pathol. 2000, 114:934-937.
59. van Hulst M., Bilgin Y.M., van de Watering L.M., et al. Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery. Transfus Med. 2005, 15:209-217.
60. Blumberg N., Heal J.M. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am. J. Med. 1996, 101:299-308.
61. Babcock G.F., Alexander J.W. The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse. Transplantation 1996, 61:465-468.
62. Blumberg N., Heal J.M. The transfusion immunomodulation theory: the Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism. Semin. Hematol. 1996, 33:329-340.
63. Baumgartner J.M., Silliman C.C., Moore E.E., Banerjee A., McCarter M.D. Stored red blood cell transfusion induces regulatory T cells. J. Am. Coll. Surg. 2009, 208:110-119.
64. Weinberg J.A., McGwin G., Griffin R.L., et al. Age of transfused blood: an independent predictor of mortality despite universal leukoreduction. J. Trauma 2008, 65:279-282.
65. discussion 282-4.
66. Koch M., Antolovic D., Reissfelder C., et al. Leucocyte-depleted blood transfusion is an independent predictor of surgical morbidity in patients undergoing elective colon cancer surgery-a single-center analysis of 531 patients. Ann. Surg. Oncol. 2011, 18:1404-1411.
67. Perisanidis C., Dettke M., Papadogeorgakis N., et al. Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. Oral Oncol. 2012, 48:372-378.
68. Ng T., Ryder B.A., Chern H., et al. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. J. Thorac. Cardiovasc. Surg. 2012, 143:815-819.
69. Ness P.M. Does transfusion of stored red blood cells cause clinically important adverse effects? A critical question in search of an answer and a plan. Transfusion 2011, 51:666-667.
70. Swindell C.G., Barker T.A., McGuirk S.P., et al. Washing of irradiated red blood cells prevents hyperkalaemia during cardiopulmonary bypass in neonates and infants undergoing surgery for complex congenital heart disease. Eur. J. Cardiothorac. Surg. 2007, 31:659-664.
71. Grimshaw K., Sahler J., Spinelli S.L., Phipps R.P., Blumberg N. New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells. Transfusion 2011, 51:874-880.
72. Khan S.Y., Kelher M.R., Heal J.M., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006, 108:2455-2462.
73. Vlaar A.P., Hofstra J.J., Levi M., et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology 2010, 113:92-103.
74. Vlaar A.P., Hofstra J.J., Kulik W., et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010, 116:1360-1368.
75. Rubin O., Crettaz D., Canellini G., Tissot J.D., Lion N. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang. 2008, 95:288-297.
76. Rubin O., Crettaz D., Tissot J.D., Lion N. Microparticles in stored red blood cells: submicron clotting bombs?. Blood Transfus. 2010, 8(Suppl. 3):s31-s38.
77. Tissot J.D., Rubin O., Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Curr. Opin. Hematol. 2010, 17:571-577.
78. Blumberg N., Heal J.M., Rowe J.M. A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord. 2004, 4:6.
79. Blumberg N., Heal J.M., Liesveld J.L., Phillips G.L., Rowe J.M. Platelet transfusion and survival in adults with acute leukemia. Leukemia 2008, 22:631-635.
80. Tynngård N., Trinks M., Berlin G. Platelet quality after washing: the effect of storage time before washing. Transfusion 2010, 50:2745-2752.
81. Tynngård N., Trinks M., Berlin G. In vitro quality of platelets during prolonged storage after washing with three platelet additive solutions. Vox Sang. 2012, 102:32-39.